Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function

Nileshkumar J. Patel, Michael Hoosien, Abhishek Deshmukh, Apurva O. Badheka, Peeyush M. Grover, Neeraj Shah, Vikas Singh, Kathan Mehta, Ankit Chothani, Ghanshyambhai T. Savani, Shilpkumar Arora, Vipulkumar Bhalara, Nilay Patel, Dhaval Khalpada, Ankit Rathod, Thomas J. Vazzana, James Lafferty, Juan F. Viles-Gonzalez, Raul D. Mitrani

Research output: Contribution to journalArticle

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)e84-e86
JournalInternational Journal of Cardiology
Volume169
Issue number5
DOIs
StatePublished - Nov 20 2013

Keywords

  • Atrial fibrillation
  • Digoxin
  • Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Patel, N. J., Hoosien, M., Deshmukh, A., Badheka, A. O., Grover, P. M., Shah, N., Singh, V., Mehta, K., Chothani, A., Savani, G. T., Arora, S., Bhalara, V., Patel, N., Khalpada, D., Rathod, A., Vazzana, T. J., Lafferty, J., Viles-Gonzalez, J. F., & Mitrani, R. D. (2013). Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function. International Journal of Cardiology, 169(5), e84-e86. https://doi.org/10.1016/j.ijcard.2013.10.040